HITK Financial Facts

GROSS PROFIT: 32.88M
Selling, general and administrative expenses: 16.54M
See Full Income Statement

Accrued expenses: 19.13M
Retained earnings: 172.92M
See Full Balance Sheet

Earnings History for Hi Tech Pharmacal Co. Inc. (HITK)

  |   Expand Research on HITK
Next EPS Date 4/8/13 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -17.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.6%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
3/7/13 Q313 $0.43$0.71 -$0.28$64.33M$60.45M N/A / N/A N/A -10.1% Details
12/6/12 Q213 $0.66$0.59 +$0.07$57.54M$56.89M N/A / N/A N/A +8.7% Details
9/5/12 Q113 $0.44$0.68 -$0.24$52M$57.6M $0.74 / $58.28M N/A -7.7% Details
7/10/12 Q412 $0.73$0.78 -$0.05$61.3M$57.94M $0.78 / $58.8M N/A +10.6% Details
12/5/11 Q212 $1.04$0.77 +$0.27$56.88M$51.4M N/A / N/A N/A -20.9% Details
9/7/11 Q112 $1.05$0.84 +$0.21$56.21M$54.07M N/A / N/A N/A +13.8% Details
7/7/11 Q411 $1.08$0.71 +$0.37$57.2M$49.33M N/A / N/A N/A +16.8% Details
3/8/12 Q411 $0.79$0.87 -$0.08$55.63M$55.73M N/A / N/A N/A -18.2% Details